Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

541

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Complicated Intra-abdominal Infections
Interventions
DRUG

Eravacycline

DRUG

Ertapenem

DRUG

Placebo

Administered IV to maintain the blind.

Trial Locations (69)

Unknown

Florence

Mobile

Glendale

La Mesa

Los Angeles

Torrance

Aurora

Carmel

Boston

Springfield

Minneapolis

Las Vegas

Camden

Teaneck

Cleveland

Columbus

Weston

Houston

Seattle

Córdoba

Pleven

Plovdiv

Rousse

Sofia

Varna

Brno

Kladno

Mělník

Olomouc

Prague

Ústí nad Labem

Kohtla-Järve

Tallinn

Tartu

Paris

Heidelberg

Lübeck

Magdeburg

Daugavpils

Liepāja

Riga

Kaunas

Klaipėda

Šiauliai

Vilnius

Bucharest

Cluj-Napoca

Craiova

Timișoara

Kaluga

Kemerovo

Moscow

Nizhny Novgorod

Saint Petersburg

Smolensk

Tomsk

Volgograd

Vsevolozhsk

Benoni

Johannesburg

Pretoria

Worcester

Dnipropetrovsk

Ivano-Frankivsk

Kharkiv

Kyiv

Odesa

Uzhhorod

Zaporizhia

All Listed Sponsors
lead

Tetraphase Pharmaceuticals, Inc

INDUSTRY

NCT01844856 - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections | Biotech Hunter | Biotech Hunter